Sun. Apr 21st, 2024

The Institute for Research and Social Development of Rare Diseases presents its “Report on neonatal screening in Spain: concept of equity”, a publication with which it intends to denounce the lack of efficiency of the basic portfolio of pathologies of the Ministry of Health, as well as the inaction to establish an expanded and unified neonatal screening program for all the autonomous communities. The newborn screening or “heel stick” It is one of the first medical procedures we undergo within a few hours of birth. This test detects andendocrine-metabolic diseases that the baby may suffer, thus making an early diagnosis that improves the quality of life of patients. It is carried out by extracting, 48 hours after birth, a few drops of blood from the heel of the newborn that are impregnated on an absorbent paper approved on both sides. Currently, the SNational Health System (SNS) Spanish only includes recognition of 7 pathologies in its basic portfolio of services: Congenital hypothyroidismPhenylketonuriaCystic FibrosisMedium-chain acyl-coenzyme A-dehydrogenase deficiency (MCADD)Long-chain 3-hydroxy-acyl-coenzymeA-dehydrogenase (LCHADD) deficiencyGlutaric acidemia type I (GA-I) Sickle cell anemia Deficit

Murcia includes more pathologies in its screening program

Cantabria is one of the communities that screens for fewer diseases. Murcia is the autonomous community that includes the most pathologies in its screening program.
Thus, each autonomous community has free will to add or alter the pathologies included in its extended neonatal screening. Is inequity it is dangerous for our children, and even more so when this screening is not expanded or unified for economic reasons. From INDEPF they fight every day to change this situation.

Your certified training at the best price!!